Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Cecy R. Xi"'
Autor:
Cecy R Xi, Arianna Di Fazio, Naveed Ahmed Nadvi, Karishma Patel, Michelle Sui Wen Xiang, Hui Emma Zhang, Chandrika Deshpande, Jason K K Low, Xiaonan Trixie Wang, Yiqian Chen, Christopher L D McMillan, Ariel Isaacs, Brenna Osborne, Ana Júlia Vieira de Ribeiro, Geoffrey W McCaughan, Joel P Mackay, W Bret Church, Mark D Gorrell
Publikováno v:
Molecules, Vol 25, Iss 22, p 5392 (2020)
Proteases catalyse irreversible posttranslational modifications that often alter a biological function of the substrate. The protease dipeptidyl peptidase 4 (DPP4) is a pharmacological target in type 2 diabetes therapy primarily because it inactivate
Externí odkaz:
https://doaj.org/article/fa9dcf2606954561b940299e84274b4d
Autor:
Arianna Di Fazio, W. Bret Church, Michelle Sui Wen Xiang, Xin Maggie Wang, Cecy R. Xi, Hui Emma Zhang, Charles G. Bailey, Geoffrey W. McCaughan, Chandrika N. Deshpande, Yiqian Chen, Naveed A. Nadvi, Mehdi Sharifi Tabar, Mark D. Gorrell
Publikováno v:
Protein expression and purification. 181
Fibroblast activation protein alpha (FAP) is a cell-surface expressed type II glycoprotein that has a unique proteolytic activity. FAP has active soluble forms that retain the extracellular portion but lack the transmembrane domain and cytoplasmic ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdd730a711316a14b9eaa1610dc00619
https://pubmed.ncbi.nlm.nih.gov/33524496
https://pubmed.ncbi.nlm.nih.gov/33524496
Autor:
Ana Julia Vieira de Ribeiro, Cecy R. Xi, Ariel Isaacs, Christopher L. D. McMillan, Arianna Di Fazio, K. Patel, Michelle Sui Wen Xiang, Mark D. Gorrell, Geoffrey W. McCaughan, Chandrika N. Deshpande, W. Bret Church, Joel P. Mackay, Brenna Osborne, Naveed A. Nadvi, Hui Emma Zhang, Yiqian Chen, Xiaonan Trixie Wang, Jason Low
Publikováno v:
Molecules
Molecules, Vol 25, Iss 5392, p 5392 (2020)
Volume 25
Issue 22
Molecules, Vol 25, Iss 5392, p 5392 (2020)
Volume 25
Issue 22
Proteases catalyse irreversible posttranslational modifications that often alter a biological function of the substrate. The protease dipeptidyl peptidase 4 (DPP4) is a pharmacological target in type 2 diabetes therapy primarily because it inactivate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5967ba4b1c4b2fd7da292bf6872c7dff
https://doi.org/10.20944/preprints202009.0390.v2
https://doi.org/10.20944/preprints202009.0390.v2
